ストックスクリーナーアプリを入手
0.1384
1.84%
0.0025
前日終値:
$0.1359
開ける：
$0.136
24時間の取引高:
2.29M
Relative Volume:
0.19
時価総額：
$9.09M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-28.73%
1か月 パフォーマンス:
-54.58%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.1311
$0.1445
1週間の範囲:
$0.1311
$0.196
52週間の値動き範囲:
$0.1159
$2.22
Profusa Inc Stock (PFSA) Company Profile
PFSA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PFSA
Profusa Inc
|
0.1384 | 5.68M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Profusa Inc (PFSA) 最新ニュース
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Profusa, Inc. (PFSA) -10.7% in Normal Trading: Decline Amid Recent Financial Update - Stocks Telegraph
Profusa raises USD 12M in gross proceeds from convertible PIPE note - Medical Buyer
Profusa Announces Q3 Highlights and Strategic Merger - TipRanks
Profusa, Inc. Announces Third Quarter 2025 Financial Results and Business Highlights - TradingView
Profusa Announces Third Quarter Business and Financial Highlights - Bluefield Daily Telegraph
Profusa, Inc. SEC 10-Q Report - TradingView
Is Profusa Inc (PFSA) positioned for future growth? - Setenews
Profusa Delays Filing of Quarterly Report - MSN
What is Profusa Inc (PFSA) Stock Return on Shareholders’ Capital? - Setenews
Profusa invests additional $1 million in digital treasury assets - MSN
Profusa, Inc. (PFSA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Profusa Inc (PFSA) looking to reclaim success with recent performance - setenews.com
Profusa, Inc. (PFSA) stock price, news, quote and history - Yahoo! Finance UK
[8-K] Profusa, Inc. Reports Material Event | PFSA SEC FilingForm 8-K - Stock Titan
Profusa outlines EU launch of tissue oxygen monitoring in 2026 - Investing.com India
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
Profusa outlines EU launch of tissue oxygen monitoring in 2026 By Investing.com - Investing.com South Africa
Profusa Unveils Strategic Plan for Revenue Growth - TipRanks
Profusa, Inc. Outlines Path to $250 Million Revenue by 2030 - TradingView
Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches - The Manila Times
Profusa Outlines Potential Path to $250 Million Revenue by - GlobeNewswire
Profusa (PFSA) Stock Skyrockets 36% on Milestone News – Can This Biotech Sensor Play Rebound? - ts2.tech
Why Profusa (PFSA) Stock Soared 36% After Hours? - Benzinga
[424B3] Profusa, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan
Profusa, Inc.Common Stock (Nasdaq:PFSA) Stock Quote | User | malvern-online.com - FinancialContent
Profusa completes manufacturing milestones ahead of 2026 product launch - Investing.com India
Profusa completes manufacturing milestones ahead of 2026 product launch By Investing.com - Investing.com Nigeria
Profusa IncOn track to provide inventory in Q1 2026 - MarketScreener
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026 - GlobeNewswire
Profusa Invests $1 Million in Digital Treasury Assets - MSN
Profusa Unveils Strategic Focus in Investor Update - MSN
Profusa expands European footprint for Lumee Oxygen platform - Investing.com India
Profusa expands European footprint for Lumee Oxygen platform By Investing.com - Investing.com Australia
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe - The Manila Times
Profusa expands sales footprint with new distributor for Lumee Oxygen platform in Europe - MarketScreener
Profusa, Inc. Expands Distribution of Lumee Oxygen Platform Across Major European Markets - Quiver Quantitative
Profusa Expands Sales Footprint with New Distributor for Lumee?? Oxygen Platform in Europe - MarketScreener
~35% EU Population Covered — Profusa Partners with Angiopro to Commercialize Lumee in Europe - Stock Titan
Profusa files prospectus relates to resale of up to 42.6 mln shares - MarketScreener
Profusa, Inc. (PFSA) latest press releases and corporate news - Yahoo! Finance UK
Profusa injects additional USD 1M into digital treasury assets - Medical Buyer
Profusa makes second $1 million bitcoin investment to hedge risks By Investing.com - ng.investing.com
Profusa, Inc. announced that it has received $1 million in funding - MarketScreener
Profusa Inc (PFSA) 財務データ
Profusa Inc (PFSA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
5.84%
大文字化:
|
ボリューム (24 時間):